Adsorption in sepsis

被引:49
作者
Ronco, C
Brendolan, A
Dan, M
Piccinni, P
Bellomo, R
De Nitti, C
Inguaggiato, P
Tetta, C
机构
[1] Renal Res Inst, New York, NY 10128 USA
[2] St Bortolo Hosp, Dept Nephrol & Intens Care, Vicenza, Italy
[3] Austin & Repatriat Med Ctr, Intens Care Unit, Melbourne, Vic, Australia
[4] Molinette Mauriziano Hosp, Baldi & Riberi Cent Labs, Turin, Italy
[5] Bellco SPA, Clin & Lab Res Dept, Mirandola, Italy
关键词
sorbent; cytokines; renal replacement therapy; plasma filtration; inflammatory cascade;
D O I
10.1046/j.1523-1755.2000.07619.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The pathophysiology of sepsis offers a highly complicated scenario. In sepsis, endotoxin or other gram-positive-derived products induce a complex and dynamic cellular response, giving rise to several mediators known to be relevant in the pathogenesis of septic shock such as specific mediators, substances responsible for up- or down-regulation of cytokine receptors and cytokine antagonists, inactivators of translational or transductional pathways, and precursor molecules. Tn this review, we delve into some new concepts stemming up from the use of sorbents in continuous plasma filtration. Nonspecific simultaneous removal of several mediators of the inflammatory cascade have led to improved outcomes in animal models of septic shock and to improved hemodynamics in a pilot clinical study. It seems of great importance to explore all possible treatment techniques that may have a direct impact on circulating mediators of sepsis and that also may interfere with the imbalance between proirflammatory and anti-inflammatory substances in the critically ill patient with multiple organ failure. Tn this view, the application of sorbents appears to open new and interesting therapeutic options. The search for innovative treatments specifically targeted to the special needs of the critically ill patients seems therefore more important than the attempt to adjust concepts and technologies that are normally applied to patients with chronic renal failure.
引用
收藏
页码:S148 / S155
页数:8
相关论文
共 32 条
[1]   Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis [J].
Astiz, M ;
Saha, D ;
Lustbader, D ;
Lin, R ;
Rackow, E .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (06) :594-600
[2]  
BEAMAN M, 1987, Q J MED, V62, P15
[3]  
Bellomo R, 1998, KIDNEY INT, V53, pS182
[4]   TREATMENT OF SEPSIS-ASSOCIATED SEVERE ACUTE-RENAL-FAILURE WITH CONTINUOUS HEMODIAFILTRATION - CLINICAL-EXPERIENCE AND COMPARISON WITH CONVENTIONAL DIALYSIS [J].
BELLOMO, R ;
FARMER, M ;
WRIGHT, C ;
PARKIN, G ;
BOYCE, N .
BLOOD PURIFICATION, 1995, 13 (05) :246-254
[5]  
Berlot G, 1998, KIDNEY INT, V53, pS178
[6]   Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes [J].
Brandtzaeg, P ;
Osnes, L ;
Ovstebo, R ;
Joo, GB ;
Westvik, AB ;
Kierulf, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :51-60
[7]   Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study [J].
Brivet, FG ;
Kleinknecht, DJ ;
Loirat, P ;
Landais, PJM ;
Bedock, B ;
Bleichner, G ;
Richard, C ;
Coste, F ;
BrunBuisson, C ;
Sicot, C ;
Tenaillon, A ;
Gajdos, P ;
Blin, F ;
Saulnier, F ;
Agostini, MM ;
Nicolas, F ;
FeryLemonnier, E ;
Staikowski, F ;
Carlet, J ;
Guivarch, G ;
Fraisse, F ;
Ricome, J ;
Tempe, JD ;
Mezzarobba, P .
CRITICAL CARE MEDICINE, 1996, 24 (02) :192-198
[8]  
Canaud B, 1995, Adv Nephrol Necker Hosp, V24, P271
[9]  
De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846
[10]   SEPTIC SHOCK - PATHOGENESIS [J].
GLAUSER, MP ;
ZANETTI, G ;
BAUMGARTNER, JD ;
COHEN, J .
LANCET, 1991, 338 (8769) :732-736